Isolated Histoplasma Tenosynovitis in a Patient on Adalimumab

Mayo Clin Proc. 2020 Jun;95(6):1212. doi: 10.1016/j.mayocp.2020.02.023.

Authors

John M Rieth¹, Stephanie J T Chen², Darus L Bennett³, Manish Suneja⁴

Affiliations

¹ Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA. Electronic address: John-rieth@uiowa.edu.
² Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA.
³ Department of Musculoskeletal Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA.
⁴ Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA.

PMID: 32498777
DOI: 10.1016/j.mayocp.2020.02.023

No abstract available

Publication types

Case Reports

MeSH terms

Adalimumab / adverse effects
Adult
Anti-Inflammatory Agents / adverse effects
Antifungal Agents / therapeutic use
Female
Hand
Histoplasma / isolation & purification
Histoplasmosis / complications*
Histoplasmosis / diagnosis
Histoplasmosis / drug therapy
Humans
Immunosuppression Therapy
Itraconazole / therapeutic use
Tenosynovitis / etiology*
Tenosynovitis / surgery

Substances

Anti-Inflammatory Agents
Antifungal Agents
Itraconazole
Adalimumab